Evidence map›Paper›PMID 40817425›Full record

ArticleMedical physics2025

Large-scale convolutional neural network for clinical target and multi-organ segmentation in gynecologic brachytherapy via multi-stage learning.

Mingzhe Hu, Yuan Gao, Yuheng Li, Richard Lj Qiu, Chih-Wei Chang, Keyur D Shah, Priyanka Kapoor, Beth Bradshaw, Yuan Shao, Justin Roper and 3 more

Abstract read
In one paragraph

Article in Medical physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Mingzhe HuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Yuan GaoDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Yuheng LiDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Richard Lj QiuDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Chih-Wei ChangDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Keyur D ShahDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Priyanka KapoorDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Beth BradshawDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Yuan ShaoSchool of Public Health, University of Illinois, Chicago, Illinois, USA.
Justin RoperDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Jill RemickDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.
Zhen TianDepartment of Radiation and Cellular Oncology, University of Chicago, Chicago, Illinois, USA.
Xiaofeng YangDepartment of Radiation Oncology and Winship Cancer Institute, Emory University, Atlanta, Georgia, USA.

Funding

eXtended Modular ANthropomorphic (XMAN) phantom for Imaging and Treatment Optimization in Radiotherapy.R01EB032680 · NIBIB · UNIVERSITY OF MARYLAND BALTIMORE · PI REN, LEI, YANG, XIAOFENG · 2022 to 2025
$2.4M
Real-time Volumetric Imaging for Motion Management and Dose Delivery VerificationR01CA272991 · NCI · EMORY UNIVERSITY · PI Zhen Tian, Xiaofeng Yang · 2023 to 2026
$2.3M
Artificial Intelligence Driven Automatic Treatment Planning of Stereotactic Radiosurgery for the Management of Multiple Brain MetastasesR37CA272755 · NCI · UNIVERSITY OF CHICAGO · PI Zhen Tian · 2022 to 2026
$1.8M
NCI NIH HHS R01 CA272991NCI NIH HHS R37 CA272755NIBIB NIH HHS R01 EB032680NIH HHS R01CA272991NIH HHS R01EB032680NIH HHS R37CA272755
6 · The paper itself

Abstract

backgroundAccurate segmentation of high-risk clinical target volume (HRCTV) and organs-at-risk (OARs) is crucial for optimizing gynecologic brachytherapy treatment planning. However, performing this segmentation on Computed Tomography (CT) images remains particularly challenging due to anatomical variability, limited soft-tissue contrast, and the scarcity of annotated datasets. Compared to other radiotherapy domains, CT-based gynecologic brachytherapy segmentation is notably underrepresented in benchmarking studies. PURPOSE: This study aims to improve the segmentation of HRCTV and OARs in gynecologic brachytherapy by introducing GynBTNet, a multi-stage learning framework. Through large-scale self-supervised pretraining and progressive finetuning, the model is designed to enhance anatomical representation learning and adapt effectively to domain-specific gynecologic structures, addressing the challenges of limited training data and complex anatomical variability.

methodsGynBTNet employs a three-stage training strategy: (1) self-supervised pretraining on large-scale CT datasets using sparse submanifold convolution to capture robust anatomical representations, (2) supervised finetuning on a multi-organ segmentation dataset to refine feature extraction, and (3) task-specific finetuning on the gynecologic brachytherapy dataset to optimize segmentation performance for clinical applications. In the third stage, 116 cases were used for training, while 29 cases were reserved for independent testing. The model was evaluated against state-of-the-art methods using the Dice Similarity Coefficient (DSC), 95th percentile Hausdorff Distance (HD95%), and Average Surface Distance (ASD). Overall statistical significance across models was assessed using the Friedman test. Post hoc pairwise comparisons were conducted using two-tailed paired permutation tests, with multi-comparison correction via the Benjamini-Hochberg procedure to control the false discovery rate. Cohen's effect sizes were calculated to quantify the performance differences.

resultsGynBTNet demonstrated consistent superiority over nnU-Net across all structures and achieved overall favorable performance compared to Swin-UNETR. The most substantial improvement was observed in HRCTV segmentation, where GynBTNet achieved a DSC of 0.837 ± 0.068, significantly higher than nnU-Net (p < 0.05) with a large effect size of +1.25, and superior to Swin-UNETR with a moderate-to-large effect size of +0.57. Boundary precision for HRCTV also improved significantly, with effect sizes in HD95% (-0.81 vs. nnU-Net, -0.52 vs. Swin-UNETR) and ASD (-1.20 vs. nnU-Net, -0.61 vs. Swin-UNETR). For bladder segmentation, GynBTNet reached a DSC of 0.940 ± 0.052, significantly outperforming nnU-Net (p < 0.05) with a large effect size of +1.28 and showing a small advantage over Swin-UNETR (effect size +0.26). In rectum segmentation, GynBTNet achieved a DSC of 0.842 ± 0.070, significantly exceeding nnU-Net (p < 0.05) with a large effect size of +1.17, and surpassing Swin-UNETR with an effect size of +0.54. For the uterus, GynBTNet significantly improved boundary accuracy compared to both nnU-Net and Swin-UNETR (p < 0.05), with effect sizes in ASD of -0.99 and -0.64. Segmentation of the sigmoid colon remained challenging, as GynBTNet provided only marginal DSC gains over nnU-Net with negligible effect sizes.

conclusionsThe proposed multi-stage learning strategy effectively enhances segmentation accuracy for gynecologic brachytherapy, leveraging large-scale self-supervised pretraining and progressive finetuning. By improving HRCTV and OARs delineation, GynBTNet has the potential to enhance treatment planning precision, minimize radiation exposure to critical structures, and improve patient outcomes.

Indexed as

BrachytherapyConvolutional Neural NetworksImage Processing, Computer-AssistedRadiotherapy Planning, Computer-AssistedFemaleHumansOrgans at RiskTomography, X-Ray Computedclinical target volume segmentationgynecologic brachytherapymulti‐stage learningorgan‐at‐risk segmentationself‐supervised pretraining

Identifiers

PMID40817425
PMCPMC12681083

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.